{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T12:14:17Z","timestamp":1720527257467},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.trim.2018.04.003","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T11:56:59Z","timestamp":1524052619000},"page":"54-58","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["CMV seronegative donors: Effect on clinical severity of CMV infection and reconstitution of CMV-specific immunity"],"prefix":"10.1016","volume":"49","author":[{"given":"P.L.J.","family":"van der Heiden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.M.","family":"van Egmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.J.","family":"Veld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"van de Meent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Eefting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.C.","family":"de Wreede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.J.M.","family":"Halkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H.F.","family":"Falkenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.A.F.","family":"Marijt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Jedema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.trim.2018.04.003_bb0005","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.V78.5.1373.1373","article-title":"Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease","volume":"78","author":"Reusser","year":"1991","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.trim.2018.04.003_bb0010","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.bmt.1705385","article-title":"Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath \u201cin the bag\u201d as T-cell depletion: the Leiden experience","volume":"37","author":"Barge","year":"2006","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"10.1016\/j.trim.2018.04.003_bb0015","first-page":"1559","article-title":"Outcomes after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with alemtuzumab","volume":"91","author":"von dem Borne","year":"2006","journal-title":"Haematologica"},{"issue":"Suppl. 1","key":"10.1016\/j.trim.2018.04.003_bb0020","first-page":"S27","article-title":"Reduced-intensity conditioning allogeneic stem cell transplantation with donor T-cell depletion using alemtuzumab added to the graft (\u2018Campath in the bag\u2019)","volume":"21","author":"von dem Borne","year":"2009","journal-title":"Curr. Opin. Oncol."},{"issue":"1","key":"10.1016\/j.trim.2018.04.003_bb0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1182\/blood-2005-07-2746","article-title":"Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications","volume":"107","author":"Chalandon","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.trim.2018.04.003_bb0030","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1128\/JCM.42.4.1498-1504.2004","article-title":"Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection","volume":"42","author":"Kalpoe","year":"2004","journal-title":"J. Clin. Microbiol."},{"issue":"7","key":"10.1016\/j.trim.2018.04.003_bb0035","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.bmt.1705311","article-title":"Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients","volume":"37","author":"van der Heiden","year":"2006","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.trim.2018.04.003_bb0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.trim.2018.04.003_bb0045","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/sj.bmt.1703024","article-title":"Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome","volume":"27","author":"Barge","year":"2001","journal-title":"Bone Marrow Transplant."},{"issue":"10","key":"10.1016\/j.trim.2018.04.003_bb0050","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0301-472X(03)00200-5","article-title":"Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors","volume":"31","author":"Barge","year":"2003","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.trim.2018.04.003_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jim.2008.07.017","article-title":"Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression","volume":"339","author":"Wehler","year":"2008","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.trim.2018.04.003_bb0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood-2006-11-056168","article-title":"Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities","volume":"110","author":"Wolfl","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.trim.2018.04.003_bb0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/CJI.0b013e318213cb90","article-title":"Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation","volume":"34","author":"Zandvliet","year":"2011","journal-title":"J. Immunother."},{"issue":"5","key":"10.1016\/j.trim.2018.04.003_bb0070","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1073\/pnas.0530192100","article-title":"Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia","volume":"100","author":"Marijt","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 1","key":"10.1016\/j.trim.2018.04.003_bb0075","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/bmt.2012.282","article-title":"Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation","volume":"48","author":"Iacobelli","year":"2013","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.trim.2018.04.003_bb0080","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.4049\/jimmunol.1701018","article-title":"High mutation frequency of the PIGA gene in T cells results in reconstitution of GPI anchor(\u2212)\/CD52(\u2212) T cells that can give early immune protection after alemtuzumab-based T cell-depleted allogeneic stem cell transplantation","volume":"200","author":"Loeff","year":"2018","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.trim.2018.04.003_bb0085","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1182\/blood-2014-07-589150","article-title":"CMV promotes recipient T-cell immunity following reduced-intensity T-cell-depleted HSCT, significantly modulating chimerism status","volume":"125","author":"Sellar","year":"2015","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.trim.2018.04.003_bb0090","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.trim.2018.04.003_bb0095","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/CJI.0b013e31826e35f6","article-title":"Effective treatment of refractory CMV reactivation after allogeneic stem cell transplantation with in vitro-generated CMV pp65-specific CD8+ T-cell lines","volume":"35","author":"Meij","year":"2012","journal-title":"J. Immunother."},{"issue":"10","key":"10.1016\/j.trim.2018.04.003_bb0100","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1038\/leu.2017.16","article-title":"Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after Allo-HSCT","volume":"31","author":"Neuenhahn","year":"2017","journal-title":"Leukemia"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327417301673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327417301673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:22:54Z","timestamp":1571185374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327417301673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":20,"alternative-id":["S0966327417301673"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2018.04.003","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CMV seronegative donors: Effect on clinical severity of CMV infection and reconstitution of CMV-specific immunity","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2018.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}